Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECAP-DM: Real-life Effectiveness and Care Patterns of Diabetes Management
2005-002118-39Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Merck & Co. Primary endpoint: Adequate glycemic control. Started Jun 2005; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-002118-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002118-39.